influenza virus vaccines

in·flu·en·za vi·rus vac·cines

influenza virus grown in embryonated eggs and inactivated, usually by the addition of formalin; both whole virus and subunit preparations containing hemagglutinins and neuraminidase are used; because of the marked and progressive antigenic variation of the influenza viruses, the strains included are regularly changed following various outbreaks of influenza to include most recently isolated epidemic strains of both type A influenza and type B influenza.
References in periodicals archive ?
Recommended composition of influenza virus vaccines for use in the 2019-2020 northern hemisphere influenza season.
The incident marked the first time Taiwan has been excluded from WHO's biannual consultation on the Composition of Influenza Virus Vaccines since 2014.
WHO recommendations on the composition of influenza virus vaccines [cited 2017 Aug 10].
Fouchier et al., "H7 avian influenza virus vaccines protect chickens against challenge with antigenically diverse isolates," Vaccine, vol.
Influenza virus vaccines are unique in that they are updated, often annually, to include the most current hemagglutinin antigens (HA) based on estimates from circulating strains.
Influenza virus vaccines are unique in that they are updated, often annually, to include the most current hemagglutinin (HA) antigens based on estimates from circulating strains.
Influenza Recommended composition of influenza virus vaccines for use in the 2015 southern hemisphere influenza season.
"NDV strains are closely related, and theoretically, vaccines do not need to be changed frequently like avian influenza virus vaccines do," Miller says.
Recommended Composition of Influenza Virus Vaccines for use in the 2014 Southern Hemisphere Influenza Season.
The ministry said Taiwan received a letter of invitation to the WHO consultation meeting on the Composition of Influenza Virus Vaccines at 1 a.m.
The WHO recommendations for influenza vaccine composition for the Southern Hemisphere 2019 season were made at the WHO Consultation and Information Meeting on the Composition of Influenza Virus Vaccines held September 24-27, 2018, in Atlanta, Georgia.